PA
PFG Advisors’s SPDR S&P Biotech ETF XBI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-14,382
| Closed | -$1.17M | – | 790 |
|
|
2025
Q1 | $1.17M | Sell |
14,382
-5,681
| -28% | -$461K | 0.07% | 304 |
|
|
2024
Q4 | $1.81M | Sell |
20,063
-70,774
| -78% | -$6.37M | 0.11% | 204 |
|
|
2024
Q3 | $8.97M | Buy |
90,837
+12,495
| +16% | +$1.23M | 0.57% | 42 |
|
|
2024
Q2 | $7.26M | Buy |
78,342
+5,018
| +7% | +$465K | 0.49% | 48 |
|
|
2024
Q1 | $6.96M | Buy |
73,324
+69,132
| +1,649% | +$6.56M | 0.51% | 46 |
|
|
2023
Q4 | $374K | Buy |
4,192
+66
| +2% | +$5.89K | 0.03% | 423 |
|
|
2023
Q3 | $301K | Buy |
4,126
+45
| +1% | +$3.29K | 0.03% | 456 |
|
|
2023
Q2 | $340K | Sell |
4,081
-2,048
| -33% | -$170K | 0.03% | 481 |
|
|
2023
Q1 | $467K | Sell |
6,129
-314
| -5% | -$23.9K | 0.04% | 398 |
|
|
2022
Q4 | $535K | Sell |
6,443
-22
| -0.3% | -$1.83K | 0.05% | 342 |
|
|
2022
Q3 | $513K | Buy |
6,465
+130
| +2% | +$10.3K | 0.06% | 317 |
|
|
2022
Q2 | $471K | Buy |
6,335
+501
| +9% | +$37.2K | 0.05% | 255 |
|
|
2022
Q1 | $524K | Buy |
5,834
+295
| +5% | +$26.5K | 0.05% | 259 |
|
|
2021
Q4 | $620K | Sell |
5,539
-496
| -8% | -$55.5K | 0.06% | 322 |
|
|
2021
Q3 | $759K | Buy |
6,035
+804
| +15% | +$101K | 0.08% | 284 |
|
|
2021
Q2 | $708K | Buy |
5,231
+815
| +18% | +$110K | 0.08% | 273 |
|
|
2021
Q1 | $599K | Buy |
4,416
+590
| +15% | +$80K | 0.08% | 268 |
|
|
2020
Q4 | $539K | Buy |
3,826
+103
| +3% | +$14.5K | 0.09% | 234 |
|
|
2020
Q3 | $441K | Buy |
+3,723
| New | +$441K | 0.08% | 243 |
|